Search results
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 14 hours agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved ...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 7 days ago"Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine" was originally...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
The Kansas City Star· 6 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy ...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 5 days agoModerna has announced that its Phase III clinical trial of the investigational next-generation Covid...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 6 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its mRNA...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 17 hours agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters· 6 days ago, opens new tab said on Thursday its next-generation COVID-19 vaccine candidate showed it was not...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 4 days ago“Based on the totality of the evidence, on June 6, 2024, FDA initially advised the manufacturers of the licensed and authorized COVID-19 vaccines ...
Gateway - Quartz
Quartz· 21 hours agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an early-phase clinical trial testing the combined use of an experimental cancer vaccine ...